Capital Advisors »

Eagle Pharmaceuticals shares owned by Capital Advisors

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $999 149 6.71
2024-06-30 $999 149 6.71
2024-03-31 $1.0k 175 5.71

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr Core Div Grwth (DGRO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Capital Advisors

Top funds holding Eagle Pharmaceuticals

Nantahala Capital Management
AIGH Capital Management
Citigroup
Vanguard Group
AQR Capital Management
BlackRock
Morgan Stanley
BlackRock
Renaissance Technologies
Two Sigma Advisers
Marshall Wace
J. Goldman & Co
Assenagon Asset Management
Two Sigma Investments
Jacobs Levy Equity Management

View all funds holding Eagle Pharmaceuticals